Protein interactions are highly diverse in their biochemical nature, varying in affinity and are often dependent on the surrounding biochemical environment. Given this heterogeneity, it seems unlikely that any one method, and particularly those capable of screening for many protein interactions in parallel, will be able to detect all functionally relevant interactions that occur within a living cell. One major class of interactions that are not detected by current popular high-throughput methods are those that occur in the extracellular environment, especially those made by membrane-embedded receptor proteins. In the present article, we discuss some of our recent research in the development of a scalable assay to identify this class of protein interaction and some of the findings from its application in the construction of extracellular protein interaction networks.
The role of extracellular protein interactions
Extracellular protein interactions are fundamental to many biological processes from maintaining structural tissue integrity to initiating complex intercellular recognition and signalling processes. Genome sequencing projects and experiments addressing this question directly [10] have revealed that up to 7000 genes encode proteins that are either secreted or in some way associated with membranes in humans. Dividing these proteins into different structural and functional classes shows that around half of these could be classed as cell-surface receptor or secreted proteins, making this class of proteins a significant proportion of the vertebrate proteome [11] . Given the fact that extracellular protein interactions are not detected in many large-scale protein interaction screens, they are therefore becoming increasingly under-represented as the number and scale of interaction screens using these techniques increases. This is a growing concern because extracellular proteins are considered clinically tractable owing to their accessibility to systemically delivered therapeutic reagents.
Why are extracellular interactions not detected by current high-throughput interaction assays?
Proteins that occupy the extracellular space and particularly those that bridge the lipid bilayer have biochemical properties that are difficult to recapitulate in heterologous expression systems. Extracellular proteins are usually glycosylated and, because they exist in an oxidizing environment, the thiol groups on cysteine residues will be oxidized to form disulfide bonds which are critical for correct folding and function. Many commonly used expression methods including Escherichia coli and cell-free systems do not add these structurally important post-translational modifications and are therefore unsuitable for detecting these interactions. In addition, membrane-embedded receptor proteins are amphipathic, containing, on the same molecule, a hydrophobic membrane-spanning region and a hydrophilic glycan coat, making them difficult to solubilize and manipulate biochemically. Solubilizing membrane proteins often requires the use of organic solvents or strongly ionic detergents which do not maintain the native conformation necessary to detect physiologically relevant interactions. Also, interaction affinities between membrane-embedded receptor proteins, when measured in their monomeric state, are extremely weak, having equilibrium dissociation constants in the micromolar range, corresponding to a halflife of fractions of a second. This is an important consideration when selecting a technique to identify these interactions, since methods that require long and stringent washing steps (such as biochemical purifications) will not detect these interactions. The fleeting nature of these interactions has evolved because membrane surfaces contain arrays of many thousands of proteins which combine additively to produce highly avid binding that nevertheless enables cells to separate easily and maintain their independent cellular motility.
Techniques that can detect extracellular interactions
Techniques developed to identify low-affinity extracellular receptor-ligand pairs must ensure that the proteins contain the structurally important post-translational modifications to ensure correct folding and function. In addition, proteins must be presented in a multivalent manner to increase the avidity of the interaction and overcome the low interaction affinities. For many cell-surface receptor proteins [e.g. type-I, type-II transmembrane and GPI (glycosylphosphatidylinositol)-anchored proteins], it is possible to express just the extracellular fragment as a soluble recombinant protein in mammalian cells and retain its binding activity. This enables the use of multimerizing protein tags such as Fc regions or alkaline phosphatase to increase the binding avidity of the reagent to enable detection of transient interactions. There are now many different multimerizing tags that have been used for this purpose (see [11] for a recent review); however, since there is no simple relationship between protein-binding affinity and avidity, each tag varies in its efficacy for a particular protein interaction pair. We [12, 13] and others [14] [15] [16] have had success using the pentamerizing coiled-coil domain from the COMP (cartilage oligomeric matrix protein), possibly because of the parallel arrangement of the coils which then cluster the ectodomains at the same end of the molecule, spatially concentrating them and making them available for simultaneous binding. Alternatively, immobilization around clustering supports either as a solid phase (such as microbeads [17, 18] ) or soluble scaffolds (e.g. dextran [19] or streptavidin [20] ) can be used. Although these techniques have been successful in identifying extracellular interactions, many of them require careful reagent quantification and validation, making them unsuitable to be scaled so that they could be applied to identify many thousands of interactions simultaneously.
Large-scale screening for novel low-affinity extracellular protein interactions
The large proportion of secreted and membrane-associated proteins in vertebrate genomes and the unsuitability of many high-throughput protein interaction techniques to detect this class of interactions made the development of a highthroughput assay capable of detecting these interactions an important priority. One consideration for scaling a protein interaction assay dedicated to detecting a particular class of protein interaction is to identify biochemical generalities so that a single approach can be applied to many proteins in parallel. A good assay should also be able to clearly separate false negatives and false positives at a given stringency for a large proportion of the interactions that are to be detected. Ideally, a set of known positives and also negatives should be used to benchmark the assay (as described in [9, 12] ) to ensure that this has been achieved. In the case of lowaffinity extracellular interactions, it was important that the assay could detect interactions that had equilibrium solution interaction strengths of at least 50 µM (t1 / 2 ∼0.1 s), since interactions weaker than this are unlikely to support spontaneous interactions at physiological surface receptor densities [21] .
There are several existing techniques that are able to detect transient protein interactions, including SPR (surface plasmon resonance), resonant acoustic profiling, isothermal calorimetry and ultracentrifugation. These techniques, however, usually require large amounts of purified protein which would make large-scale screening prohibitive. Nevertheless, SPR has been used in the commercial sector where resources permit the creation of large recombinant protein libraries. One study screened a library of over 2000 recombinant proteins using SPR to identify a single novel receptor-ligand pair involved in regulating T-cell activation [22] . Similarly, a large library of Fc fusion proteins was used to screen a panel of cell lines transiently transfected with cDNAs encoding cell-surface receptors; again, just a single interaction was reported [23] .
Protein complementation assays have been developed to detect extracellular or intramembranous protein interactions in yeast which use control of yeast growth as a proxy to detect interactions. For example, the SCINEX-P (screening for interactions between extracellular proteins) assay makes use of an ER (endoplasmic reticulum)-localized receptor protein that normally functions as part of the unfolded protein response pathway, Ire1p [24] . The Ire1p receptor becomes signal-competent upon dimerization of its ERluminal domains located within the oxidizing environment of the secretory pathway. SCINEX-P was used to show that high-affinity (K d in the nanomolar range) antibody-antigen interactions could be detected using this method. Because the signalling of Ire1p is reconstituted by proteins that interact within the same membrane, this assay could be particularly useful for detecting receptor interactions that occur in cis.
Two other papers have reported the overall results of large systematic protein interaction screens which are both based on expressing soluble ectodomain fragments in cells that add appropriate post-translational modifications and using an ELISA-style assay to specifically detect interactions. The first reported an assay to determine the binding specificity of the many splice variants of the Drosophila Dscam protein.
The ectodomain fragments were expressed in Drosophila S2 insect cells and normalized, and screens testing over 3000 interactions clearly showed the homophilic binding specificity of the Dscam protein [25] . The assay is based on a two construct bait-prey system using dimerizing tags: the Fc region of human IgG 1 and alkaline phosphatase. The second method, aimed at detecting novel heterophilic receptorligand pairs was developed in our laboratory and is called AVEXIS (avidity-based extracellular interaction screen) [12] . AVEXIS detects direct physical interactions between soluble recombinant ectodomain fragments expressed in mammalian cells using monomeric biotinylated baits which were arrayed on streptavidin-coated microtitre plates and a pentamerized β-lactamase-tagged prey. Importantly, the levels of the proteins are normalized before adding them to the screen, since, despite using standardized procedures, we have found that the level at which the proteins are expressed varied by several orders of magnitude. The biophysical binding properties of several interacting pairs identified in our high-throughput screen were determined using SPR, and we showed that this assay was able to detect interactions with half-lives of a tenth of a second or less when measured in their monomeric form.
We have now compiled a protein library of 249 ectodomain fragments of cell-surface and secreted proteins, mainly belonging to the zebrafish Ig and leucine-rich repeat protein families and systematically screened for interactions between them in both bait-prey orientations using AVEXIS. This represents a total of over 62 000 potential interactions screened from which we have identified 118 interactions, the majority of which were novel. The use of the zebrafish model enabled us to determine the tissue-expression patterns for all of the genes within our library using whole mount in situ hybridization at several key stages of larval development. These data were then integrated with the interaction network to identify which interactions were spatiotemporally compatible (because they were expressed at the same time or place) and also resolve the interactions into tissue-and stage-specific interaction networks (S. Martin, C. Söllner, V. Charoensawan, B. Adryan, B. Thisse, S. Teichmann and G.J. Wright, unpublished work). We have made these integrated data available in a publicly accessible website called ARNIE (AVEXIS Receptor Network with Integrated Expression; http://www.sanger.ac.uk/arnie). We found that the large majority of the interactions that we had identified (76 %) were spatiotemporally compatible, providing independent support for their biological relevance and clues to their function. Separating the interactions into different tissue systems showed that the majority of genes encoding interacting receptor-ligand pairs were compatibly expressed in the developing nervous system, highlighting the high demand for intercellular recognition events within this tissue. With this in mind, we have begun the process of building a neuroreceptor interaction map which will ultimately be used to provide a molecular explanation for the wiring of vertebrate nervous systems [13] .
Do extracellular protein interaction networks differ from other protein interaction networks?
By using our library of recombinant proteins and AVEXIS, we have compiled the largest extracellular protein interaction network published to date, enabling us to compare, for the first time, its properties with those of more extensive cytoplasmic networks and have found both similarities and differences. One of the salient features of cytoplasmic protein interaction networks is that they are scale-free, containing a small number of highly connected 'hubs' and a larger number of proteins that form fewer interactions [26] . Similarly, our extracellular protein interaction network showed that the connectivity distribution behaved as an inverse power law. Also, similarly to cytoplasmic protein interaction networks, we found that extracellular protein interaction networks are enriched for interactions between paralogous proteins: a protein is more likely to interact with another protein with which it shares some sequence homology than with any other protein.
In comparison with cytoplasmic protein interaction networks, our extracellular protein interaction network contained more homophilic interactions (17 % compared with 2-3 %). This was unexpected, since the main class of false negatives using our assay, when compared with the literature, are homophilic interactions, a phenomenon that we explain by prey-prey association 'masking' potential prey-bait interactions [12] . It is currently unclear whether this phenomenon has physiological significance or if it is an artefact of the assay. Finally, we examined whether the subcellular localization affected connectivity within the network and found that secreted proteins were, on average, almost twice as connected as membrane-tethered receptors.
Conclusions
We have shown that, using AVEXIS, it is now possible to begin the large-scale mapping of extracellular proteinprotein interactions, a class of interactions that are not routinely detected using other high-throughput protein interaction assays. This now enables the construction of extracellular protein interaction networks that underlie molecular recognition processes used between cells within a multicellular organism. We are now applying this technique to cell recognition systems that have a more direct clinical application including receptor-ligand interactions involved in platelet aggregation and host-pathogen interactions. This will enable us to connect extracellular binding events to intracellular signalling pathways by integrating extracellular interactions with more extensive cytoplasmic interaction networks. Finally, given the heterogeneity in the biophysical nature of protein interactions and the different biochemical environments in which they occur, the goal of mapping a complete and accurate protein interaction network will only be met if more protein interaction assays dedicated to identify particular subclasses of protein interaction are developed.
